BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11339288)

  • 1. Simultaneous determination of buprenorphine, norbuprenorphine, and buprenorphine-glucuronide in plasma by liquid chromatography-tandem mass spectrometry.
    Polettini A; Huestis MA
    J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(2):447-59. PubMed ID: 11339288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry.
    Concheiro-Guisan M; Shakleya DM; Huestis MA
    Anal Bioanal Chem; 2009 May; 394(2):513-22. PubMed ID: 19247639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry.
    Concheiro M; Shakleya DM; Huestis MA
    Forensic Sci Int; 2009 Jul; 188(1-3):144-51. PubMed ID: 19406593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Huang W; Moody DE; McCance-Katz EF
    Ther Drug Monit; 2006 Apr; 28(2):245-51. PubMed ID: 16628138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine and major metabolites in blood specimens collected for drug analysis in law enforcement purposes.
    Oechsler S; Skopp G
    Forensic Sci Int; 2010 Feb; 195(1-3):73-7. PubMed ID: 20006453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatographic/electrospray ionization tandem mass spectrometric analysis for the quantification of buprenorphine, norbuprenorphine, buprenorphine-3-beta-D-glucuronide and norbuprenorphine-3-beta-D-glucuronide in human plasma.
    Murphy CM; Huestis MA
    J Mass Spectrom; 2005 Jan; 40(1):70-4. PubMed ID: 15637731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Online solid-phase extraction liquid chromatography-electrospray-tandem mass spectrometry analysis of buprenorphine and three metabolites in human urine.
    Liu AC; Lin TY; Su LW; Fuh MR
    Talanta; 2008 Mar; 75(1):198-204. PubMed ID: 18371868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.
    Concheiro M; Jones H; Johnson RE; Shakleya DM; Huestis MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):13-20. PubMed ID: 19945361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of buprenorphine, norbuprenorphine, naloxone, and their glucuronides in urine by liquid chromatography-tandem mass spectrometry.
    Mariottini C; Gergov M; Ojanperä I
    Drug Test Anal; 2021 Sep; 13(9):1658-1667. PubMed ID: 34047070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentials of ion trap collisional spectrometry for liquid chromatography/electrospray ionization tandem mass spectrometry determination of buprenorphine and nor-buprenorphine in urine, blood and hair samples.
    Favretto D; Frison G; Vogliardi S; Ferrara SD
    Rapid Commun Mass Spectrom; 2006; 20(8):1257-65. PubMed ID: 16550495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of buprenorphine, norbuprenorphine, and metabolites in human urine.
    Kacinko SL; Concheiro-Guisan M; Shakleya DM; Huestis MA
    Anal Bioanal Chem; 2008 Nov; 392(5):903-11. PubMed ID: 18758763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive determination of buprenorphine and its N-dealkylated metabolite norbuprenorphine in human plasma by liquid chromatography coupled to tandem mass spectrometry.
    Ceccato A; Klinkenberg R; Hubert P; Streel B
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):619-31. PubMed ID: 12899952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of buprenorphine, norbuprenorphine and naloxone in human plasma by liquid chromatography/tandem mass spectrometry.
    Liu Y; Li X; Xu A; Nasser AF; Heidbreder C
    J Pharm Biomed Anal; 2016 Feb; 120():142-52. PubMed ID: 26730511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of buprenorphine in human plasma by gas chromatography-positive ion chemical ionization mass spectrometry and liquid chromatography-tandem mass spectrometry.
    Moody DE; Laycock JD; Spanbauer AC; Crouch DJ; Foltz RL; Josephs JL; Amass L; Bickel WK
    J Anal Toxicol; 1997 Oct; 21(6):406-14. PubMed ID: 9323518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid quantification of buprenorphine-glucuronide and norbuprenorphine-glucuronide in human urine by LC-MS-MS.
    Hegstad S; Khiabani HZ; Øiestad EL; Berg T; Christophersen AS
    J Anal Toxicol; 2007 May; 31(4):214-9. PubMed ID: 17555645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a gas chromatography-mass spectrometry method for the simultaneous determination of buprenorphine, flunitrazepam and their metabolites in rat plasma: application to the pharmacokinetic study.
    Pirnay S; Bouchonnet S; Hervé F; Libong D; Milan N; D'Athis P; Baud F; Ricordel I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):335-42. PubMed ID: 15203048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplified processing and rapid quantification of buprenorphine, norbuprenorphine, and their conjugated metabolites in human plasma using UPLC-MS/MS: Assessment of buprenorphine exposure during opioid use disorder treatment.
    Zhao W; Alshogran OY; Zhang H; Joshi A; Krans EE; Caritis S; Shaik IH; Venkataramanan R
    J Mass Spectrom; 2024 Apr; 59(4):e5015. PubMed ID: 38501738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography-mass spectrometry.
    Regina KJ; Kharasch ED
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():23-31. PubMed ID: 24095872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of buprenorphine, norbuprenorphine and naloxone in fingernail clippings and urine of patients under opioid substitution therapy.
    Tzatzarakis MN; Vakonaki E; Kovatsi L; Belivanis S; Mantsi M; Alegakis A; Liesivuori J; Tsatsakis AM
    J Anal Toxicol; 2015 May; 39(4):313-20. PubMed ID: 25663675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid chromatography-mass spectrometric analysis of buprenorphine and its N-dealkylated metabolite norbuprenorphine in rat brain tissue and plasma.
    Yue H; Borenstein MR; Jansen SA; Raffa RB
    J Pharmacol Toxicol Methods; 2005; 52(3):314-22. PubMed ID: 15935707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.